Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 256 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2020-04-23 | 2020-05-21 | 113028 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-04-23 | 2020-08-27 | 113031 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-04-23 | 2020-11-26 | 113034 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2020-04-23 | 2020-07-23 | 113037 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113040 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-23 | 2020-05-08 | 113043 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-05-01 | 2020-05-08 | 113726 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-05-01 | 2020-05-08 | 113729 |
| TEVA-BROMAZEPAM | 3MG | TABLET | Resolved | 2020-05-01 | 2020-05-08 | 113732 |
| TEVA-QUININE | 200MG | CAPSULE | Resolved | 2020-05-01 | 2020-06-18 | 113735 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2020-05-01 | 2020-05-21 | 113738 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113741 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-05-01 | 2020-06-04 | 113746 |
| TEVA-SILDENAFIL | 25MG | TABLET | Resolved | 2020-05-01 | 2020-05-08 | 113749 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113752 |
| TEVA-CHLORPROMAZINE | 100MG | TABLET | Resolved | 2020-05-01 | 2020-05-08 | 113755 |
| TEVA-SILDENAFIL | 50MG | TABLET | Resolved | 2020-05-01 | 2020-09-17 | 113758 |
| TEVA-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-05-01 | 2020-05-21 | 113761 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2020-05-01 | 2020-05-14 | 113764 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Resolved | 2020-05-01 | 2020-06-04 | 113767 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |